185 related articles for article (PubMed ID: 20706122)
1. Circulating tumor cells and emerging blood biomarkers in breast cancer.
Criscitiello C; Sotiriou C; Ignatiadis M
Curr Opin Oncol; 2010 Nov; 22(6):552-8. PubMed ID: 20706122
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
Mostert B; Sleijfer S; Foekens JA; Gratama JW
Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of circulating tumor cells in primary and metastatic breast cancer.
Aurilio G; Sciandivasci A; Munzone E; Sandri MT; Zorzino L; Cassatella MC; Verri E; Rocca MC; Nolè F
Expert Rev Anticancer Ther; 2012 Feb; 12(2):203-14. PubMed ID: 22316368
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells in breast cancer.
Ignatiadis M; Georgoulias V; Mavroudis D
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
[TBL] [Abstract][Full Text] [Related]
5. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
6. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery.
Sandri MT; Zorzino L; Cassatella MC; Bassi F; Luini A; Casadio C; Botteri E; Rotmensz N; Adamoli L; Nolè F
Ann Surg Oncol; 2010 Jun; 17(6):1539-45. PubMed ID: 20135356
[TBL] [Abstract][Full Text] [Related]
7. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
9. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
Pestrin M; Bessi S; Galardi F; Truglia M; Biggeri A; Biagioni C; Cappadona S; Biganzoli L; Giannini A; Di Leo A
Breast Cancer Res Treat; 2009 Dec; 118(3):523-30. PubMed ID: 19597704
[TBL] [Abstract][Full Text] [Related]
10. Longtime recirculating tumor cells in breast cancer patients.
Pachmann K
Clin Cancer Res; 2005 Aug; 11(15):5657; author reply 5657-8. PubMed ID: 16061886
[No Abstract] [Full Text] [Related]
11. [Circulating stem cells: a comparison of breast cancer and cardiovascular pathology].
Bershteĭn LM
Vopr Onkol; 2009; 55(5):528-33. PubMed ID: 20020646
[No Abstract] [Full Text] [Related]
12. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
14. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
Alunni-Fabbroni M; Sandri MT
Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
[TBL] [Abstract][Full Text] [Related]
16. HER2 as marker for the detection of circulating tumor cells.
Müller V; Pantel K
Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
[No Abstract] [Full Text] [Related]
17. Circulating tumor cells in patients with breast cancer dormancy.
Meng S; Tripathy D; Frenkel EP; Shete S; Naftalis EZ; Huth JF; Beitsch PD; Leitch M; Hoover S; Euhus D; Haley B; Morrison L; Fleming TP; Herlyn D; Terstappen LW; Fehm T; Tucker TF; Lane N; Wang J; Uhr JW
Clin Cancer Res; 2004 Dec; 10(24):8152-62. PubMed ID: 15623589
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E
Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970
[TBL] [Abstract][Full Text] [Related]
19. By the numbers: does circulating tumor cell enumeration have a role in metastatic breast cancer?
Liu MC
J Clin Oncol; 2014 Nov; 32(31):3479-82. PubMed ID: 25245442
[No Abstract] [Full Text] [Related]
20. Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge.
Vermeulen PB; van Golen KL; Dirix LY
Cancer; 2010 Jun; 116(11 Suppl):2748-54. PubMed ID: 20503405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
